Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

[Multiple sclerosis and immuno-modulators of sphingosine 1-phosphate receptors].

Talmont F, Hatzoglou A, Cuvillier O.

Med Sci (Paris). 2020 Mar;36(3):243-252. doi: 10.1051/medsci/2020026. Epub 2020 Mar 31. French.

PMID:
32228843
2.

Development and characterization of sphingosine 1-phosphate receptor 1 monoclonal antibody suitable for cell imaging and biochemical studies of endogenous receptors.

Talmont F, Moulédous L, Baranger M, Gomez-Brouchet A, Zajac JM, Deffaud C, Cuvillier O, Hatzoglou A.

PLoS One. 2019 Mar 7;14(3):e0213203. doi: 10.1371/journal.pone.0213203. eCollection 2019.

3.

p27Kip1 regulates the microtubule bundling activity of PRC1.

Perchey RT, Serres MP, Nowosad A, Creff J, Callot C, Gay A, Manenti S, Margolis RL, Hatzoglou A, Besson A.

Biochim Biophys Acta Mol Cell Res. 2018 Nov;1865(11 Pt A):1630-1639. doi: 10.1016/j.bbamcr.2018.08.010. Epub 2018 Aug 16.

4.

[Sphingosine 1-phosphate as a new regulator of mitosis].

Cuvillier O, Hatzoglou A.

Med Sci (Paris). 2018 Feb;34(2):112-114. doi: 10.1051/medsci/20183402003. Epub 2018 Feb 16. French. No abstract available.

5.

Sphingosine 1-Phosphate signaling controls mitosis.

Cuvillier O, Hatzoglou A.

Oncotarget. 2017 Nov 7;8(70):114414-114415. doi: 10.18632/oncotarget.22310. eCollection 2017 Dec 29. No abstract available.

6.

Sphingosine 1-phosphate signaling through its receptor S1P5 promotes chromosome segregation and mitotic progression.

Andrieu G, Ledoux A, Branka S, Bocquet M, Gilhodes J, Walzer T, Kasahara K, Inagaki M, Sabbadini RA, Cuvillier O, Hatzoglou A.

Sci Signal. 2017 Mar 28;10(472). pii: eaah4007. doi: 10.1126/scisignal.aah4007.

PMID:
28351953
7.

Gem GTPase acts upstream Gmip/RhoA to regulate cortical actin remodeling and spindle positioning during early mitosis.

Andrieu G, Quaranta M, Leprince C, Cuvillier O, Hatzoglou A.

Carcinogenesis. 2014 Nov;35(11):2503-11. doi: 10.1093/carcin/bgu185. Epub 2014 Aug 30.

PMID:
25173885
8.

The GTPase Gem and its partner Kif9 are required for chromosome alignment, spindle length control, and mitotic progression.

Andrieu G, Quaranta M, Leprince C, Hatzoglou A.

FASEB J. 2012 Dec;26(12):5025-34. doi: 10.1096/fj.12-209460. Epub 2012 Sep 10.

PMID:
22964304
9.

RalA and RalB proteins are ubiquitinated GTPases, and ubiquitinated RalA increases lipid raft exposure at the plasma membrane.

Neyraud V, Aushev VN, Hatzoglou A, Meunier B, Cascone I, Camonis J.

J Biol Chem. 2012 Aug 24;287(35):29397-405. doi: 10.1074/jbc.M112.357764. Epub 2012 Jun 14.

10.

SH3BP1, an exocyst-associated RhoGAP, inactivates Rac1 at the front to drive cell motility.

Parrini MC, Sadou-Dubourgnoux A, Aoki K, Kunida K, Biondini M, Hatzoglou A, Poullet P, Formstecher E, Yeaman C, Matsuda M, Rossé C, Camonis J.

Mol Cell. 2011 Jun 10;42(5):650-61. doi: 10.1016/j.molcel.2011.03.032.

11.

Opioids increase bladder cancer cell migration via bradykinin B2 receptors.

Vassou D, Notas G, Hatzoglou A, Castanas E, Kampa M.

Int J Oncol. 2011 Sep;39(3):697-707. doi: 10.3892/ijo.2011.1063. Epub 2011 Jun 3.

PMID:
21643624
12.

The membrane-tubulating potential of amphiphysin 2/BIN1 is dependent on the microtubule-binding cytoplasmic linker protein 170 (CLIP-170).

Meunier B, Quaranta M, Daviet L, Hatzoglou A, Leprince C.

Eur J Cell Biol. 2009 Feb;88(2):91-102. doi: 10.1016/j.ejcb.2008.08.006. Epub 2008 Nov 12.

PMID:
19004523
13.

Opioids modulate constitutive B-lymphocyte secretion.

Vassou D, Bakogeorgou E, Kampa M, Dimitriou H, Hatzoglou A, Castanas E.

Int Immunopharmacol. 2008 May;8(5):634-44. doi: 10.1016/j.intimp.2008.01.002. Epub 2008 Jan 28.

PMID:
18387505
14.

Gem associates with Ezrin and acts via the Rho-GAP protein Gmip to down-regulate the Rho pathway.

Hatzoglou A, Ader I, Splingard A, Flanders J, Saade E, Leroy I, Traver S, Aresta S, de Gunzburg J.

Mol Biol Cell. 2007 Apr;18(4):1242-52. Epub 2007 Jan 31.

15.

Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells.

Kampa M, Kogia C, Theodoropoulos PA, Anezinis P, Charalampopoulos I, Papakonstanti EA, Stathopoulos EN, Hatzoglou A, Stournaras C, Gravanis A, Castanas E.

Mol Cancer Ther. 2006 May;5(5):1342-51.

16.

Activation of membrane estrogen receptors induce pro-survival kinases.

Alexaki VI, Charalampopoulos I, Kampa M, Nifli AP, Hatzoglou A, Gravanis A, Castanas E.

J Steroid Biochem Mol Biol. 2006 Feb;98(2-3):97-110. Epub 2006 Jan 18.

PMID:
16414261
17.

RalB mobilizes the exocyst to drive cell migration.

Rossé C, Hatzoglou A, Parrini MC, White MA, Chavrier P, Camonis J.

Mol Cell Biol. 2006 Jan;26(2):727-34.

18.

Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo.

Hatzoglou A, Kampa M, Kogia C, Charalampopoulos I, Theodoropoulos PA, Anezinis P, Dambaki C, Papakonstanti EA, Stathopoulos EN, Stournaras C, Gravanis A, Castanas E.

J Clin Endocrinol Metab. 2005 Feb;90(2):893-903. Epub 2004 Dec 7.

PMID:
15585562
19.

Opioid-somatostatin interactions in regulating cancer cell growth.

Hatzoglou A, Kampa M, Castanas E.

Front Biosci. 2005 Jan 1;10:244-56. Print 2005 Jan 1. Review.

PMID:
15574365
20.

Estrogen exerts neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation.

Alexaki VI, Charalampopoulos I, Kampa M, Vassalou H, Theodoropoulos P, Stathopoulos EN, Hatzoglou A, Gravanis A, Castanas E.

FASEB J. 2004 Oct;18(13):1594-6. Epub 2004 Aug 2.

PMID:
15289442
21.

The opioid agonist ethylketocyclazocine reverts the rapid, non-genomic effects of membrane testosterone receptors in the human prostate LNCaP cell line.

Kampa M, Papakonstanti EA, Alexaki VI, Hatzoglou A, Stournaras C, Castanas E.

Exp Cell Res. 2004 Apr 1;294(2):434-45.

PMID:
15023532
22.

Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action.

Kampa M, Alexaki VI, Notas G, Nifli AP, Nistikaki A, Hatzoglou A, Bakogeorgou E, Kouimtzoglou E, Blekas G, Boskou D, Gravanis A, Castanas E.

Breast Cancer Res. 2004;6(2):R63-74. Epub 2003 Dec 15.

23.

The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton.

Kampa M, Papakonstanti EA, Hatzoglou A, Stathopoulos EN, Stournaras C, Castanas E.

FASEB J. 2002 Sep;16(11):1429-31. Epub 2002 Jul 18.

PMID:
12205037
24.

Rapid effects of 17beta-estradiol and progesterone on sheep visceral and parietal pleurae via a nitric oxide pathway.

Hatzoglou C, Gourgoulianis KI, Hatzoglou A, Castanas E, Molyvdas PA.

J Appl Physiol (1985). 2002 Aug;93(2):752-8.

25.

Natural antisense RNA inhibits the expression of BCMA, a tumour necrosis factor receptor homologue.

Hatzoglou A, Deshayes F, Madry C, Laprée G, Castanas E, Tsapis A.

BMC Mol Biol. 2002 Apr 18;3:4. Epub 2002 Apr 18.

26.

Opioids are non-competitive inhibitors of nitric oxide synthase in T47D human breast cancer cells.

Kampa M, Hatzoglou A, Notas G, Niniraki M, Kouroumalis E, Castanas E.

Cell Death Differ. 2001 Sep;8(9):943-52.

27.

Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines.

Kampa M, Hatzoglou A, Notas G, Damianaki A, Bakogeorgou E, Gemetzi C, Kouroumalis E, Martin PM, Castanas E.

Nutr Cancer. 2000;37(2):223-33.

PMID:
11142097
28.

Somatostatin and opioid receptors in mammary tissue. Role in cancer cell growth.

Hatzoglou A, Bakogeorgou E, Kampa M, Panagiotou S, Martin PM, Loukas S, Castanas E.

Adv Exp Med Biol. 2000;480:55-63. Review.

PMID:
10959409
30.

Potent inhibitory action of red wine polyphenols on human breast cancer cells.

Damianaki A, Bakogeorgou E, Kampa M, Notas G, Hatzoglou A, Panagiotou S, Gemetzi C, Kouroumalis E, Martin PM, Castanas E.

J Cell Biochem. 2000 Jun 6;78(3):429-41.

PMID:
10861841
31.

Opioid agonists modify breast cancer cell proliferation by blocking cells to the G2/M phase of the cycle: involvement of cytoskeletal elements.

Panagiotou S, Bakogeorgou E, Papakonstanti E, Hatzoglou A, Wallet F, Dussert C, Stournaras C, Martin PM, Castanas E.

J Cell Biochem. 1999 May 1;73(2):204-11.

PMID:
10227383
32.

Kappa1-opioid binding sites are the dominant opioid binding sites in surgical specimens of human pheochromocytomas and in a human pheochromocytoma (KAT45) cell line.

Kampa M, Margioris AN, Hatzoglou A, Dermitzaki I, Denizot A, Henry JF, Oliver C, Gravanis A, Castanas E.

Eur J Pharmacol. 1999 Jan 8;364(2-3):255-62.

PMID:
9932731
33.

The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily.

Madry C, Laabi Y, Callebaut I, Roussel J, Hatzoglou A, Le Coniat M, Mornon JP, Berger R, Tsapis A.

Int Immunol. 1998 Nov;10(11):1693-702.

PMID:
9846698
35.

Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors.

Kampa M, Bakogeorgou E, Hatzoglou A, Damianaki A, Martin PM, Castanas E.

Eur J Pharmacol. 1997 Sep 24;335(2-3):255-65.

PMID:
9369381
36.

Taxol inhibits opioid binding on T47D human breast cancer cells.

Bakogeorgou E, Hatzoglou A, Castanas E.

Biochem Biophys Res Commun. 1997 Jun 9;235(1):201-4.

PMID:
9196063
37.

Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth.

Hatzoglou A, Bakogeorgou E, Papakonstanti E, Stournaras C, Emmanouel DS, Castanas E.

J Cell Biochem. 1996 Dec 15;63(4):410-21.

PMID:
8978457
38.
39.

Antiproliferative and receptor binding properties of alpha- and beta-casomorphins in the T47D human breast cancer cell line.

Hatzoglou A, Bakogeorgou E, Hatzoglou C, Martin PM, Castanas E.

Eur J Pharmacol. 1996 Aug 29;310(2-3):217-23.

PMID:
8884220
40.
41.

Identification, characterization and localization of corticotropin-releasing hormone receptors in human placenta.

Hatzoglou A, Margioris AN, Bakogeorgou E, Gravanis A, Castanas E.

Life Sci. 1996;59(22):1871-9.

PMID:
8950284
42.

Morphine cross-reacts with somatostatin receptor SSTR2 in the T47D human breast cancer cell line and decreases cell growth.

Hatzoglou A, Ouafik L, Bakogeorgou E, Thermos K, Castanas E.

Cancer Res. 1995 Dec 1;55(23):5632-6.

43.

Identification and characterization of opioid-binding sites present in the Ishikawa human endometrial adenocarcinoma cell line.

Hatzoglou A, Gravanis A, Margioris AN, Zoumakis E, Castanas E.

J Clin Endocrinol Metab. 1995 Feb;80(2):418-23.

PMID:
7852499
44.

Estrogen and progesterone receptors in breast cancer microsamples simultaneously quantified by enzyme-ligand immunoassay.

Krambovitis E, Hatzidakis G, Hatzoglou A, Romain S, Durand A, Stefanakis A, Castanas E.

Clin Chem. 1995 Jan;41(1):48-53.

PMID:
7813080
45.

Acidification reveals a greater number of epidermal growth factor receptors in human placental and breast cancer membranes.

Hatzoglou A, Romain S, Dalapascha H, Castanas E.

Clin Chim Acta. 1994 Jun;227(1-2):97-109.

PMID:
7955425
46.

Protein measurement of particulate and solubilized ovine liver membranes.

Hatzoglou A, Prekezes J, Tsami M, Castanas E.

Ann Clin Biochem. 1992 Nov;29 ( Pt 6):659-62.

PMID:
1489162

Supplemental Content

Loading ...
Support Center